LYDIA RENICH: Open Payments
NPI 1659564409 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$983 in 58 payments from 13 companies in 2025. Trend: 2023 $1,021 · 2024 $774 · 2025 $983
Food & beverage: $983
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 13 | $254 |
| ABBVIE INC. | 18 | $248 |
| Lilly USA, LLC | 5 | $124 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $103 |
| GENZYME CORPORATION | 2 | $46 |
| Intercept Pharmaceuticals, Inc. | 3 | $45 |
| PFIZER INC. | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 2 | $34 |
| Ipsen Biopharmaceuticals, Inc | 2 | $28 |
| QOL Medical, LLC | 1 | $21 |
Products named: TREMFYA, OMVOH, SKYRIZI, ENTYVIO, DUPIXENT, RINVOQ, OCALIVA, CREON.
Industry payments across KS — which companies pay providers there.
